Technical Analysis for TVTX - Travere Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 8.28 | 0.73% | 0.06 |
TVTX closed up 0.73 percent on Monday, July 1, 2024, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Spinning Top | Other | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Bearish Engulfing | Bearish | 0.73% | |
Slingshot Bullish | Bullish Swing Setup | 0.73% | |
Volume Surge | Other | 0.73% | |
Upper Bollinger Band Walk | Strength | 0.73% | |
Overbought Stochastic | Strength | 0.73% | |
Upper Bollinger Band Touch | Strength | 0.73% |
Alert | Time |
---|---|
Possible NR7 | about 6 hours ago |
Slingshot Bullish Entry | about 9 hours ago |
Rose Above Previous Day's High | about 9 hours ago |
Up 2% | about 9 hours ago |
Up 1% | about 10 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/01/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 17.5699 |
52 Week Low | 5.12 |
Average Volume | 1,254,581 |
200-Day Moving Average | 7.66 |
50-Day Moving Average | 6.79 |
20-Day Moving Average | 7.56 |
10-Day Moving Average | 7.75 |
Average True Range | 0.43 |
RSI (14) | 66.56 |
ADX | 28.49 |
+DI | 29.71 |
-DI | 13.36 |
Chandelier Exit (Long, 3 ATRs) | 7.09 |
Chandelier Exit (Short, 3 ATRs) | 8.09 |
Upper Bollinger Bands | 8.44 |
Lower Bollinger Band | 6.67 |
Percent B (%b) | 0.91 |
BandWidth | 23.35 |
MACD Line | 0.36 |
MACD Signal Line | 0.28 |
MACD Histogram | 0.0868 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.73 | ||||
Resistance 3 (R3) | 8.72 | 8.55 | 8.66 | ||
Resistance 2 (R2) | 8.55 | 8.44 | 8.56 | 8.63 | |
Resistance 1 (R1) | 8.42 | 8.37 | 8.49 | 8.43 | 8.60 |
Pivot Point | 8.25 | 8.25 | 8.29 | 8.26 | 8.25 |
Support 1 (S1) | 8.12 | 8.14 | 8.19 | 8.13 | 7.96 |
Support 2 (S2) | 7.95 | 8.07 | 7.96 | 7.93 | |
Support 3 (S3) | 7.82 | 7.95 | 7.91 | ||
Support 4 (S4) | 7.83 |